Literature DB >> 33183613

Composite inclusion complexes containing hyaluronic acid/chitosan nanosystems for dual responsive enrofloxacin release.

Yuda Liu1, Dongmei Chen2, Aoxue Zhang1, Man Xiao3, Zhenxia Li4, Wanhe Luo4, Yuanhu Pan4, Wei Qu4, Shuyu Xie5.   

Abstract

In order to overcome treatment difficulty of S. aureus infections, a pH/hyaluronidase dual responsive enrofloxacin-cyclodextrin (β-CD) inclusion complexes (IC) containing hyaluronic acid/chitosan (HA/CS) self-assemble composite nanosystems covered by poloxamer 188 (F68) was firstly explored for targeted "on-demand" delivery. The FTIR, DSC and PXRD showed that enrofloxacin was embedded into IC and then distributed into F68 coating nanogels formulated by electrostatic interaction between CS and HA. The optimal nanosystems of 118.8 ± 30.7 nm showed excellent stability and responsive release in the acid medium, hyaluronidase containing medium, and LB broth medium where S. aureus present. The nanosystems displayed strong surface adsorption on S. aureus and enhanced activity against S. aureus. It had stronger sustained release than the polymeric nanoparticles formulated by entrapping of IC into F68 and the single HA/CS nanogels. This study provides a promising multi-functionalized nanosystems to overcome the treatment challenge of S. aureus and other bacterial infections.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Hyaluronic acid/chitosan nanogels; Hyaluronidase responsiveness; Inclusion complexes; Staphylococcus aureus; pH responsiveness

Mesh:

Substances:

Year:  2020        PMID: 33183613     DOI: 10.1016/j.carbpol.2020.117162

Source DB:  PubMed          Journal:  Carbohydr Polym        ISSN: 0144-8617            Impact factor:   9.381


  8 in total

Review 1.  Hyaluronic Acid-Based Nanomaterials as a New Approach to the Treatment and Prevention of Bacterial Infections.

Authors:  Reza Alipoor; Mohammad Ayan; Michael R Hamblin; Reza Ranjbar; Somaye Rashki
Journal:  Front Bioeng Biotechnol       Date:  2022-06-08

2.  Antibacterial activity of enrofloxacin loaded gelatin-sodium alginate composite nanogels against intracellular Staphylococcus aureus small colony variants.

Authors:  Wanhe Luo; Jinhuan Liu; Samah Attia Algharib; Wei Chen
Journal:  J Vet Sci       Date:  2022-05       Impact factor: 1.603

3.  Enhanced antibacterial activity of tilmicosin against Staphylococcus aureus small colony variants by chitosan oligosaccharide-sodium carboxymethyl cellulose composite nanogels.

Authors:  Wanhe Luo; Jinhuan Liu; Shanling Zhang; Wei Song; Samah Attia Algharib; Wei Chen
Journal:  J Vet Sci       Date:  2021-11-05       Impact factor: 1.672

4.  Targeting therapy effects of composite hyaluronic acid/chitosan nanosystems containing inclusion complexes.

Authors:  Zhiwei Liang; Dongmei Chen
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

Review 5.  Exploring the applications of hyaluronic acid-based nanoparticles for diagnosis and treatment of bacterial infections.

Authors:  Mahir Mohammed; Nikita Devnarain; Eman Elhassan; Thirumala Govender
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2022-04-29

6.  Antibacterial activity of florfenicol composite nanogels against Staphylococcus aureus small colony variants.

Authors:  Jinhuan Liu; Mujie Ju; Yifei Wu; Nannan Leng; Samah Attia Algharib; Wanhe Luo
Journal:  J Vet Sci       Date:  2022-09       Impact factor: 1.603

7.  Intelligent-Responsive Enrofloxacin-Loaded Chitosan Oligosaccharide-Sodium Alginate Composite Core-Shell Nanogels for On-Demand Release in the Intestine.

Authors:  Wanhe Luo; Mujie Ju; Jinhuan Liu; Samah Attia Algharib; Ali Sobhy Dawood; Shuyu Xie
Journal:  Animals (Basel)       Date:  2022-10-08       Impact factor: 3.231

8.  Hybrid Nanobeads for Oral Indomethacin Delivery.

Authors:  Flávia Monique Rocha Bonetti; Eneida de Paula; Belchiolina Beatriz Fonseca; Gabriela Ribeiro da Silva; Leandro Santana Soares da Silva; Ludmilla David de Moura; Márcia Cristina Breitkreitz; Gustavo Henrique Rodrigues da Silva; Lígia Nunes de Morais Ribeiro
Journal:  Pharmaceutics       Date:  2022-03-08       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.